FDA Updates Labeling on Febrile Seizure Risks i...

By João L. Carapinha

January 19, 2026

FDA Labeling Mandate on Febrile Seizure Risks In a significant update to vaccine safety protocols, the U.S. Food and Drug Administration (FDA) has required pediatric influenza vaccines t...
Equity-Based Pricing: Enhancing Value in Primary Care through Socioeconomic C...
β-Blockers Myocardial Infarction: Reevaluating Their Role in Patients with Pr...
mRNA Vaccine Advancements: Transforming Infectious Disease Prevention and Equity
Positive ARTISTRY-2 Trial Results for BIC LEN HIV Regimen
Translational Medicine Portugal: Driving Collaborative Innovations in Healthcare
2025 China Drug Catalog Boosts Access with 114 New Drugs and Innovative Solut...
NICE Approves Seven Digital Cardiac Rehabilitation Technologies for Enhanced ...
Repurposing Off-Patent Medicines: Insights from the EU Pilot Initiative
Patient-Reported Outcomes Trends in Clinical Trials: Insights from 2008-2023
Health Investment Returns: Harnessing Health as a Strategic Economic Asset
Accelerated UK Clinical Trial Reforms: Enhancing Approvals with AI and Effici...
Shifting Toward Sustainable Reimbursement Models in South Africa’s Heal...